TRACON PHARMACEUTICALS, INC.
Profile
Company Names
TRACON PHARMACEUTICALS, INC.
TRACON PHARMACEUTICALS INC
Addresses
4350 LA JOLLA VILLAGE DRIVE, SUITE 800, SAN DIEGO, CA 92122
8910 UNIVERSITY CENTER DRIVE, SUITE 700, SAN DIEGO, CA 92122
4510 EXECUTIVE DRIVE, STE 330, SAN DIEGO, CA 92121
4510 EXECUTIVE DRIVE, SUITE 330, SAN DIEGO, CA 92121
Phone Numbers
858-550-0780
(858) 550-0780
8585500780
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY, PHARMACEUTICALS
Year Incorporated:
> 5 years ago
State Incorporated:
DELAWARE
Total Amount Raised:
$57,713,736.00
Number of Funding Rounds:
4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2018-03-27
$38,673,734.00
$75,670,770.00
$36,997,036.00
Equity
3
2017-03-14
$1,000,000.00
$21,000,000.00
$20,000,000.00
Equity
2
2011-03-28
$16,500,002.00
$24,500,000.00
$7,999,998.00
Equity
1
2010-03-12
$1,540,000.00
$3,000,000.00
$1,460,000.00
Debt
People
First Name
Middle Name
Last Name
Titles
Related Companies
HIRONORI
HOZOJI
DIRECTOR
J.
JAY
LOBELL
DIRECTOR
CHARLES
P.
THEUER
EXECUTIVE OFFICER, DIRECTOR
J.
RAINER
TWIFORD
DIRECTOR
CAHABA PHARMACEUTICALS, LLC
| BROOKLINE POPE ASSET FUND II, LLC
| CAPITAL STRATEGIES ADVISORS FUND II, LLC
| BROOKLINE POPE ASSET FUND I, LLC
| CSA BIOTECHNOLOGY FUND II, LLC
| TRACON PHARMACEUTICALS INC
| BROOKLINE TRACON INVESTMENT FUND II, LLC
| BROOKLINE CORONADO INVESTMENT FUND, LLC
| BROOKLINE VALUE INVESTMENT FUND, LLC
| CAMP ONE VENTURES, LLC
| BROOKLINE SPECIAL SITUATIONS FUND, LLC
| CAMP ONE VENTURES (FUND C), LLC
| TRACON PHARMACEUTICALS, INC.
| SOLARIS VC, LLC (SERIES A)
| BROOKLINE SPV, LLC (SERIES D)
| BROOKLINE SPV, LLC (SERIES E)
| BROOKLINE SPV, LLC - SERIES F
| BROOKLINE SPV, LLC - SERIES G
| BROOKLINE SPV, LLC - SERIES H
PAUL
WALKER
DIRECTOR
TED
WANG
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2018-03-27
D
BIOTECHNOLOGY
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
DECLINE TO DISCLOSE
Equity
2017-03-14
